nach oben

International Journal of Colorectal Disease

Erschienen in:

01.10.2010 | Review

Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease—review of the literature

verfasst von: Andreas G. Wibmer, Anton J. Kroesen, Jörn Gröne, Heinz-Johannes Buhr, Joerg-Peter Ritz

Erschienen in: International Journal of Colorectal Disease | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Stricturing Crohn’s disease is accompanied by a high-risk for bowel resection and subsequent short bowel syndrome. Strictureplasty (SP) and endoscopic balloon dilatation (EBD) have been developed to prevent, or at least delay, the requirement for resection. The goal of this study was to compare the outcome of these two procedures with regard to complications and disease recurrence.

Methods

We conducted a MEDLINE literature search to give a current overview about the safety and efficacy of EBD and SP.

Results

The initial search yielded 744 articles. Case reports, reviews and meta-analyses were excluded. Finally, 63 articles (SP, 40 articles; EBD, 23 articles) were used for the review. None of the studies compared the two methods directly. A total of 2,532 patients (SP, n = 1,958; EBD, n = 574) were included. The incidence of perioperative complications after SP was 11% and the incidence of major complications was 5%. The median surgical recurrence rate was 24% after a median follow-up of 46 months. The median technical success for EBD was 90%. Major complications occurred in 3% of the cases. According to an intention-to-treat protocol, the median surgical recurrence rate was 27.6%. Per-protocol analysis revealed a median surgical recurrence rate of 21.4% after a median follow-up of 21 months.

Conclusion

Due to the lack of comparable data, there is currently no reliable information on whether one treatment option is superior to the other. Regarding the limited applicability of EBD in strictures of the small bowel, only a controlled trial would provide evidence as a basis for clinical decision making in CD strictures that are potentially treatable by EBD and SP.

Bernstein CN, Blanchard JF, Rawsthorne P et al (2006) The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101:1559–1568CrossRefPubMed

Pavlovic-Calic N, Salkic NN, Gegic A, Smajic M, Alibegovic E (2008) Crohn’s disease in Tuzla region of Bosnia and Herzegovina: a 12-year study (1995-2006). Int J Colorectal Dis 23:957–964CrossRefPubMed

Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease. Gut 39:690–697CrossRefPubMed

Jess T, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ 3rd, Munkholm P, Sandborn WJ (2006) Survival and cause specific mortality in patients with inflammatory bowel disease: a long-term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 55:1248–1254CrossRefPubMed

Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A (2008) The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol 20:917–923CrossRefPubMed

Stange EF, Schreiber S, Fölsch UR, von Herbay A, Schölmerich J, Hoffmann J, Zeitz M, Fleig WE, Buhr HJ, Kroesen AJ, Moser G, Matthes H, Adler G, Reinshagen M, Stein J, German Society for Digestive and Metabolic Diseases (2003) Diagnostics and treatment of Crohn’s disease—results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases. Z Gastroenterol 41:19–20CrossRefPubMed

Timmer A, Breuer-Katschinski B, Goebell H (1999) Time trends in the incidence and disease location of Crohn’s disease 1980-1995: a prospective analysis in an urban population in Germany. Inflamm Bowel Dis 5:79–84CrossRefPubMed

Loftus EV, Schoenfeld P, Sandborn WJ (2002) The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Therap 16:51–60CrossRef

Hoffmann JC, Preiss JC, Autschbach F, Buhr HJ, Häuser W, Herrlinger K, Höhne W, Koletzko S, Krieglstein CF, Kruis W, Matthes H, Moser G, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Sido B, Siegmund B, Stallmach A, Bokemeyer B, Stange EF, Zeitz M (2008) Clinical practice guideline on diagnosis and treatment of Crohn’s disease. Z Gastroenterol 46:1094–1146CrossRefPubMed

10.

Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J (2001) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49:777–782CrossRefPubMed

11.

Gasche C, Schölmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ (2002) A simple classification of Crohn’s disease: report of Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8–15CrossRef

12.

Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I, IBSEN Study Group (2007) Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 5:1430–1438CrossRefPubMed

13.

Brenmoehl J, Falk W, Göke M, Schölmerich J, Rogler G (2008) Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF). Int J Colorectal Dis 23:947–955CrossRefPubMed

14.

Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8:244–250CrossRefPubMed

15.

Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP (2005) Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 54:237–241CrossRefPubMed

16.

Cao Y, Gao F, Liao C, Tan A, Mo Z (2009) Meta-analysis of medical treatment and placebo treatment for preventing postoperative recurrence in Crohn’s disease (CD). Int J Colorectal Dis 24:509–520CrossRefPubMed

17.

Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP (2008) The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. Int J Colorectal Dis 23:1213–1221CrossRefPubMed

18.

Heuman R, Boeryd B, Bolin T, Sjödahl R (1983) The influence of disease at the margin of resection on the outcome of Crohn’s disease. Br J Surg 70:519–521CrossRefPubMed

19.

Pennington L, Hamilton SR, Bayless TM, Cameron JL (1980) Surgical management of Crohn’s disease. Influence of disease at margin of resection. Ann Surg 192:311–318CrossRefPubMed

20.

Fazio VW, Marchetti F, Church M, Goldblum JR, Lavery C, Hull TL, Milsom JW, Strong SA, Oakley JR, Secic M (1996) Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg 224:563–571CrossRefPubMed

21.

Wolters FL, Russel MG, Stockbrügger RW (2004) Systematic review: has disease outcome in Crohn’s disease changed during the last four decades? Aliment Pharmacol Ther 20:483–496CrossRefPubMed

22.

McLeod RS, Wolff BG, Ross S, Parkes R, McKenzie M, Investigators of the CAST Trial (2009) Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum 52:919–927PubMed

23.

Travis SP, Stange EF, Lémann M, Oresland T, Chowers Y, Forbes A, D’Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ, European Crohn’s and Colitis Organisation (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut 55(Suppl 1):i16–i35CrossRefPubMed

24.

Iesalnieks I, Kilger A, Glass H, Müller-Wille R, Klebl F, Ott C, Strauch U, Piso P, Schlitt HJ, Agha A (2008) Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome. Int J Colorectal Dis 23:1167–1174CrossRefPubMed

25.

Katariya RN, Sood S, Rao PG, Rao PL (1977) Stricture-plasty for tubercular strictures of the gastro-intestinal tract. Br J Surg 64:496–498CrossRefPubMed

26.

Lee EC, Papaioannou N (1982) Minimal surgery for chronic obstruction in patients with extensive or universal Crohn’s disease. Ann R Coll Surg Engl 64:229–233PubMed

27.

Yamamoto T, Fazio VW, Tekkis PP (2007) Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum 50:1968–1986CrossRefPubMed

28.

Yuan JG, Sachar DB, Koganei K, Greenstein AJ (1994) Enterolithiasis, refractory anemia, and strictures of Crohn’s disease. J Clin Gastroenterol 18:105–108CrossRefPubMed

29.

Michelassi F (1996) Side-to-side isoperistaltic strictureplasty for multiple Crohn’s strictures. Dis Colon Rectum 39:345–349CrossRefPubMed

30.

Poggioli G, Stocchi L, Laureti S et al (1997) Conservative surgical management of terminal ileitis: side-to-side enterocolic anastomosis. Dis Colon Rectum 40:234–239CrossRefPubMed

31.

Di Abriola GF, De Angelis P, Dall’oglio L, Di Lorenzo M (2003) Strictureplasty: an alternative approach in long segment bowel stenosis Crohn’s disease. J Pediatr Surg 38:814–818CrossRefPubMed

32.

Gaetini A, DeSimone M, Resegotti A (1989) Our experience with strictureplasty in the surgical treatment of Crohn’s disease. Hepatogastroenterology 36:511–515PubMed

33.

Sasaki I, Shibata C, Funayama Y et al (2004) New reconstructive procedure after intestinal resection for Crohn’s disease: modified side-to-side isoperistaltic anastomosis with double Heineke-Mikulicz procedure. Dis Colon Rectum 47:940–943CrossRefPubMed

34.

Oliva L, Wyllie R, Alexander F et al (1994) The results of strictureplasty in pediatric patients with multifocal Crohn’s disease. J Pediatr Gastroenterol Nutr 18:306–310CrossRefPubMed

35.

Kendall GP, Hawley PR, Nicholls RJ, Lennard-Jones JE (1986) Strictureplasty. A good operation for small bowel Crohn’s disease? Dis Colon Rectum 29:312–316CrossRefPubMed

36.

Pritchard TJ, Schoetz DJ Jr, Caushaj FP et al (1990) Strictureplasty of the small bowel in patients with Crohn’s disease. An effective surgical option. Arch Surg 125:715–717PubMed

37.

Yamamoto T, Bain IM, Connolly AB, Allan RN, Keighley MR (1999) Outcome of strictureplasty for duodenal Crohn’s disease. Br J Surg 86:259–262CrossRefPubMed

38.

Worsey MJ, Hull T, Ryland L, Fazio V (1999) Strictureplasty is an effective option in the operative management of duodenal Crohn’s disease. Dis Colon Rectum 42:596–600CrossRefPubMed

39.

Roy P, Kumar D (2006) Strictureplasty for active Crohn’s disease. Int J Colorectal Dis 21:427–432CrossRefPubMed

40.

Silverman RE, McLeod RS, Cohen Z (1989) Strictureplasty in Crohn’s disease. Can Assoc Clin Surg 32:19–22

41.

Rentsch M, Beham A, Schlitt HJ, Jauch KW (2006) Crohn’s disease activity index and Vienna classification—is it worthwhile to calculate before surgery? Dig Surg 23:241–249CrossRefPubMed

42.

Laurent S, Detry O, Detroz B et al (2002) Strictureplasty in Crohn’s disease: short- and long-term follow-up. Acta Chir Belg 102:253–255PubMed

43.

Keighley MR (1991) Stapled strictureplasty for Crohn’s disease. Dis Colon Rectum 34:945–947CrossRefPubMed

44.

Fichera A, Lovadina S, Rubin M, Cimino F, Hurst RD, Michelassi F (2006) Patterns and operative treatment of recurrent Crohn’s disease: a prospective longitudinal study. Surgery 140:649–654CrossRefPubMed

45.

Quandalle P, Gambiez L, Colombel JF, Paris JC, Cortot A (1994) Long-term follow-up of strictureplasty in Crohn’s disease. Acta Gastroenterol Belg 57:314–319PubMed

46.

Roy P, Kumar D (2006) Intervention-free interval following strictureplasty for Crohn’s Disease. World J Surg 30:1020–1026CrossRefPubMed

47.

Broering DC, Eisenberger CF, Koch A et al (2001) Strictureplasty for large bowel stenosis in Crohn’s disease: quality of life after surgical therapy. Int J Colorectal Dis 16:81–87CrossRefPubMed

48.

Tonelli F, Fedi M, Paroli GM, Fazi M (2004) Indications and results of side-to-side isoperistaltic strictureplasty in Crohn’s disease. Dis Colon Rectum 47:494–501CrossRefPubMed

49.

Dasari BV, Maxwell R, Gardiner KR (2010) Assessment of complications following strictureplasty for small bowel Crohn’s Disease. Ir J Med Sci 179:201–205CrossRefPubMed

50.

Spencer MP, Nelson H, Wolff BG, Dozois RR (1994) Strictureplasty for obstructive Crohn’s disease: the Mayo experience. Mayo Clin Proc 69:33–36PubMed

51.

Yamamoto T, Keighley MRB (1999) Follow up of more than 10 years after strictureplasty for jejunileal Crohn’s disease: long-term results and predictive factors for outcome. Colorectal Dis 1:101–106CrossRef

52.

Serra J, Cohen Z, McLeod RS (1995) Natural history of strictureplasty in Crohn’s disease: 9-year experience. Can J Surg 38:481–485PubMed

53.

Tonelli F, Ficari F (2000) Strictureplasty in Crohn’s disease: surgical option. Dis Colon Rectum 43:920–926CrossRefPubMed

54.

Cristaldi M, Sampietro GM, Danelli PG, Bollani S, Bianchi Porro G, Taschieri AM (2000) Long-term results and multivariate analysis of prognostic factors in 138 consecutive patients operated on for Crohn’s disease using “bowel-sparing” techniques. Am J Surg 179:266–270CrossRefPubMed

55.

Stebbing JF, Jewell DP, Kettlewell MG, Mortensen NJ (1995) Recurrence and reoperation after strictureplasty for obstructive Crohn’s disease: long-term results [corrected]. Br J Surg 82:1471–1474, Erratum in. Br J Surg 1996;83:131CrossRefPubMed

56.

Hurst RD, Michelassi F (1998) Strictureplasty for Crohn’s disease: techniques and long-term results. World J Surg 22:359–363CrossRefPubMed

57.

Shatari T, Clark MA, Yamamoto T, Menon A, Keh C, Alexander-Williams J, Keighley M (2004) Long strictureplasty is as safe and effective as short strictureplasty in small-bowel Crohn’s disease. Colorectal Dis 6:438–441CrossRefPubMed

58.

Baba S, Nakai K (1995) Strictureplasty for Crohn’s disease in Japan. J Gastroenterol 30(Suppl 8):135–138PubMed

59.

Greenstein AJ, Zhang LP, Miller AT, Yung E, Branco BC, Sachar DB, Greenstein AJ (2009) Relationship of the number of Crohn’s strictures and strictureplasties to postoperative recurrence. J Am Coll Surg 208:1065–1070CrossRefPubMed

60.

Fearnhead NS, Chowdhury R, Box B, George BD, Jewell DP, Mortensen NJ (2006) Long-term follow-up of strictureplasty for Crohn’s disease. Br J Surg 93:475–482CrossRefPubMed

61.

Sampietro GM, Cristaldi M, Maconi G et al (2004) A prospective, longitudinal study of nonconventional strictureplasty in Crohn’s disease. J Am Coll Surg 199:82CrossRef

62.

Futami K, Arima S (2005) Role of strictureplasty in surgical treatment of Crohn’s disease. J Gastroenterol 40(Suppl 16):35–39CrossRefPubMed

63.

Yamamoto T, Bain IM, Allan RN, Keighley MR (1999) An audit of strictureplasty for small-bowel Crohn’s disease. Dis Colon Rectum 42:797–803CrossRefPubMed

64.

Ozuner G, Fazio VW, Lavery IC, Church JM, Hull TL (1996) How safe is strictureplasty in the management of Crohn’s disease? Am J Surg 171:57–61CrossRefPubMed

65.

Michelassi F, Taschieri A, Tonelli F, Sasaki I, Poggioli G, Fazio V, Upadhyay G, Hurst R, Sampietro GM, Fazi M, Funayama Y, Pierangeli F (2007) An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn’s disease. Dis Colon Rectum 50:277–284CrossRefPubMed

66.

Dietz DW, Laureti S, Strong SA et al (2001) Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg 192:330–338CrossRefPubMed

67.

Kozarek RA (1986) Hydrostatic balloon dilation of gastrointestinal stenoses: a national survey. Gastrointest Endosc 32:15–19CrossRefPubMed

68.

Brower RA (1986) Hydrostatic balloon dilation of a terminal ileal stricture secondary to Crohn’s disease. Gastrointest Endosc 32:38–40CrossRefPubMed

69.

Matsui T, Hatakeyama S, Ikeda K, Yao T, Takenaka K, Sakurai T (1997) Long-term outcome of endoscopic balloon dilation in obstructive gastroduodenal Crohn’s disease. Endoscopy 29:640–645CrossRefPubMed

70.

Williams AJ, Palmer KR (1991) Endoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn’s disease. Br J Surg 78:453–454CrossRefPubMed

71.

Tsujikawa T, Saitoh Y, Andoh A, Imaeda H, Hata K, Minematsu H, Senoh K, Hayafuji K, Ogawa A, Nakahara T, Sasaki M, Fujiyama Y (2008) Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy 40:11–15CrossRefPubMed

72.

Junge U, Züchner H (1994) Endoscopic balloon dilatation of symptomatic strictures in Crohn’s disease. Dtsch Med Wochenschr 119:1377–1382CrossRefPubMed

73.

Pohl J, May A, Nachbar L, Ell C (2007) Diagnostic and therapeutic yield of push-and-pull enteroscopy for symptomatic small bowel Crohn’s disease strictures. Eur J Gastroenterol Hepatol 19:529–534CrossRefPubMed

74.

Ramboer C, Verhamme M, Dhondt E, Huys S, Van Eygen K, Vermeire L (1995) Endoscopic treatment of stenosis in recurrent Crohn’s disease with balloon dilation combined with local corticosteroid injection. Gastrointest Endosc 42:252–255CrossRefPubMed

75.

East JE, Brooker JC, Rutter MD, Saunders BP (2007) A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn’s strictures. Clin Gastroenterol Hepatol 5:1065–1069CrossRefPubMed

76.

Brooker JC, Beckett CG, Saunders BP, Benson MJ (2003) Long-acting steroid injection after endoscopic dilation of anastomotic Crohn’s strictures may improve the outcome: a retrospective case series. Endoscopy 35:333–337CrossRefPubMed

77.

Singh VV, Draganov P, Valentine J (2005) Efficacy and safety of endoscopic balloon dilation of symptomatic upper and lower gastrointestinal Crohn’s disease strictures. J Clin Gastroenterol 39:284–290CrossRefPubMed

78.

Breysem Y, Janssens JF, Coremans G, Vantrappen G, Hendrickx G, Rutgeerts P (1992) Endoscopic balloon dilation of colonic and ileo-colonic Crohn’s strictures: long-term results. Gastrointest Endosc 38:142–147CrossRefPubMed

79.

Foster EN, Quiros JA, Prindiville TP (2008) Long-term follow-up of the endoscopic treatment of strictures in pediatric and adult patients with inflammatory bowel disease. J Clin Gastroenterol 42:880–885CrossRefPubMed

80.

Dear KL, Hunter JO (2001) Colonoscopic hydrostatic balloon dilatation of Crohn’s strictures. J Clin Gastroenterol 33:315–318CrossRefPubMed

81.

Fukumoto A, Tanaka S, Yamamoto H, Yao T, Matsui T, Iida M, Goto H, Sakamoto C, Chiba T, Sugano K (2007) Diagnosis and treatment of small-bowel stricture by double balloon endoscopy. Gastrointest Endosc 66:S108–S112CrossRefPubMed

82.

Stienecker K, Gleichmann D, Neumayer U, Glaser HJ, Tonus C (2009) Long-term results of endoscopic balloon dilatation of lower gastrointestinal tract strictures in Crohn’s disease: a prospective study. World J Gastroenterol 15:2623–2627CrossRefPubMed

83.

Hoffmann JC, Heller F, Faiss S, von Lampe B, Kroesen AJ, Wahnschaffe U, Schulzke JD, Zeitz M, Bojarski C (2008) Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness. Int J Colorectal Dis 23:689–696CrossRefPubMed

84.

Blomberg B, Rolny P, Jarnerot G (1991) Endoscopic treatment of anastomotic strictures in Crohn’s disease. Endoscopy 23:195–198CrossRefPubMed

85.

Raedler A, Peters I, Schreiber S (1997) Treatment with azathioprine and budesonide prevents reoccurrence of ileocolonic stenoses after endoscopic dilatation in Crohn’s disease (Abstract). Gastroenterology 112:A1067

86.

Ajlouni Y, Iser JH, Gibson PR (2007) Endoscopic balloon dilatation of intestinal strictures in Crohn’s disease: safe alternative to surgery. J Gastroenterol Hepatol 22:486–490CrossRefPubMed

87.

Sabate JM, Villarejo J, Bouhnik Y et al (2003) Hydrostatic balloon dilatation of Crohn’s strictures. Aliment Pharmacol Ther 18:409–413CrossRefPubMed

88.

Morini S, Hassan C, Lorenzetti R et al (2003) Long-term outcome of endoscopic pneumatic dilatation in Crohn’s disease. Dig Liver Dis 35:893–897CrossRefPubMed

89.

Ferlitsch A, Reinisch W, Puspok A et al (2006) Safety and efficacy of endoscopic balloon dilation for treatment of Crohn’s disease strictures. Endoscopy 38:483–487CrossRefPubMed

90.

Couckuyt H, Gevers AM, Coremans G, Hiele M, Rutgeerts P (1995) Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective longterm analysis. Gut 36:577–580CrossRefPubMed

91.

Thomas-Gibson S, Brooker JC, Hayward CM, Shah SG, Williams CB, Saunders BP (2003) Colonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol 15:485–488CrossRefPubMed

92.

Tichansky D, Cagir B, Yoo E, Marcus SM, Fry RD (2000) Strictureplasty for Crohn’s disease: meta-analysis. Dis Colon Rectum 43:911–919CrossRefPubMed

93.

Hassan C, Zullo A, De Francesco V, Ierardi E, Giustini M, Pitidis A, Taggi F, Winn S, Morini S (2007) Systematic review: endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther 26:1457–1464CrossRefPubMed

Titel: Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease—review of the literature
verfasst von: Andreas G. Wibmer
Anton J. Kroesen
Jörn Gröne
Heinz-Johannes Buhr
Joerg-Peter Ritz
Publikationsdatum: 01.10.2010
Verlag: Springer-Verlag
Erschienen in: International Journal of Colorectal Disease / Ausgabe 10/2010
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-010-1010-x

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2010

New insights into the development and differentiation of the human anorectal epithelia. Are there clinical consequences?

Single-incision laparoscopic low anterior resection for rectal cancer

Erratum to: Transcutaneous electrical posterior tibial nerve stimulation for faecal incontinence: effects on symptoms and quality of life

Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers

Adiponectin and resistin: biomarker for colorectal cancer?

Nuclear expression of CXCR4 is associated with advanced colorectal cancer

Update Chirurgie